Check out CRN's latest press releases in our feed, or search for your topics of interest. Members of the media, learn more here about working with CRN for science-based information for your reporting.
CRN remains committed to its support of Mandatory Product Listing (MPL) despite the advancement of the drug user fee bill, the FDASLA Act of 2022, without including provisions to increase transparency for dietary supplements.
Read more
Read more